Glassia Approved
Links shared publicly online about this topic
Glassia approved for treating alpha 1 antitrypsin deficiency - ONA
oncologynurseadvisor.com — “Kamada announced that the FDA has approved Glassia (alpha1-proteinase inhibitor liquid) for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (AATD).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 6, 2010 at 3:53 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Glassia approved for treating alpha 1 antitrypsin deficiency http://goo.gl/fb/xUQkp
Glassia approved for treating alpha 1 antitrypsin deficiency - MPR
empr.com — “Kamada announced that the FDA has approved Glassia (alpha1-proteinase inhibitor liquid) for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (AATD).” View full resource at empr.com
Most Recently Shared on July 6, 2010 at 3:33 pm By:
MPR News: Glassia approved for treating alpha 1 antitrypsin deficiency: Kamada announced that the FDA has approved... http://bit.ly/bedZ9o
Kamada Wins FDA Approval for Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency
drugs.com — “Glassia (alpha1-proteinase inhibitor (human)) is used to treat Alpha 1 deficiency. Includes Glassia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 7, 2010 at 9:27 am By:
FDA Approves Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency - http://bit.ly/bpOUdG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
